RALPH HIRSCHFELD: Open Payments
NPI 1144523077 · PUTNAM, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,603 in 412 payments from 19 companies in 2025. Trend: 2023 $6,611 · 2024 $5,640 · 2025 $6,603
Food & beverage: $6,468Education: $135
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 79 | $1,067 |
| E.R. Squibb & Sons, L.L.C. | 57 | $881 |
| Axsome Therapeutics, Inc. | 46 | $592 |
| Teva Pharmaceuticals USA, Inc. | 21 | $490 |
| Vanda Pharmaceuticals Inc. | 18 | $433 |
| Neurocrine BioSciences, Inc. | 36 | $417 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $375 |
| Otsuka America Pharmaceutical, Inc. | 17 | $350 |
| Corium, LLC | 21 | $309 |
| ABBVIE INC. | 25 | $289 |
Products named: CAPLYTA, COBENFY, REXULTI, FANAPT, INGREZZA, TRINTELLIX, Sunosi, Azstarys.
Industry payments across CT — which companies pay providers there.
